Orgenesis inks Koligo buyout to gain COVID-19 cell therapy

Orgenesis inks Koligo buyout to gain COVID-19 cell therapy

Submitted by admin on September 29, 2020 - 11:47am
Source: 
Fierce Biotech
News Tags: 
Orgenesis
M&A
Koligo Therapeutics
autologous cell therapy
COVID-19
Headline: 
Orgenesis inks Koligo buyout to gain COVID-19 cell therapy
snippet: 

Orgenesis has struck a deal to acquire Koligo Therapeutics. The takeover will give Orgenesis control of an autologous cell therapy treatment for respiratory disease caused by COVID-19.

Do Not Allow Advertisers to Use My Personal information